Damage index changes in patients with systemic sclerosis: a retrospective analysis over a five-year period
Objective: to estimate the changes of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI) over a five-year period in patients with systemic sclerosis (SS) according to the clinical type of the disease and the use of low doses of glucocorticoids (GCs), methotrexate (MTX), and hydroxychl...
Saved in:
Main Authors: | A. V. Petrov, E. S. Krutikov, A. S. Gaffarova, A. A. Petrov, A. A. Gorlov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2020-02-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/2842 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The use of the Scleroderma Clinical Trials Consortium Damage Index in systemic sclerosis
by: L. P. Ananyeva, et al.
Published: (2025-03-01) -
Use of disease-modifying anti-rheumatic drugs in the therapy of osteoarthritis
by: S. G. Anikin, et al.
Published: (2019-05-01) -
TIME COURSE OF STRUCTURAL AND FUNCTIONAL CHANGES IN THE MYOCARDIAL ARTERIES OF PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH METHOTREXATE AND HYDROXYCHLOROQUINE DURING A 4-YEAR FOLLOW-UP PERIOD
by: A. V. Petrov, et al.
Published: (2016-07-01) -
A 16-week multicenter observational study of the efficiency and safety of rheumatoid arthritis therapy with methotrexate
by: R. M. Balabanova
Published: (2018-12-01) -
Cardiotoxic Drugs Used in the Treatment of COVID-19
by: A. S. Zmitrukevich, et al.
Published: (2024-01-01)